Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
distribution of immune cells using analyses such as immunohistochemistry or immunofluorescence. You will have expertise in developing multi-parameter (>4 colour) immunofluorescence approaches, experience in
-
will be educated to PhD level with relevant experience in molecular plant biology and evolution and will work closely with other group members to assist them with gene functional characterisation
-
Hospital site in Oxford – a friendly, welcoming place of work with an international reputation for excellence. The Department has a substantial research programme, with major funding from Medical Research
-
these processes, with the aim of understanding how ageing promotes CH progression. You will hold a PhD within the area of molecular biology or have thesis submitted at time of application, and will have experience
-
the Uehiro Oxford Institute. This role would be suitable for an individual who would like to gain research experience prior to applying for PhD study. About us Based in Littlegate House, the Uehiro Oxford
-
PREVIOUS APPLICANTS NEED NOT TO APPLY! We are seeking to appoint a Senior Postdoctoral Researcher in Genomics of Myeloid Disorders to join the computational genomics group led by Prof Schuster
-
Sleep theme. As a theme member the post holder will benefit from exciting opportunities for training and career development, which may prepare the post holder to apply for a PhD/DPhil. The post holder
-
sustainable commuting options, including a cycle loan scheme, discounted bus travel, and season ticket loans. Access to a vibrant community through our social, cultural, and sports clubs. About You Hold a PhD
-
and structural biology of rhomboid-like membrane proteins. You should hold a PhD/DPhil in a topic relevant to structural biology and biochemistry, together with relevant experience. You should be able
-
for candidates interested in acquiring experience of research in a world-class academic unit (see http://www.wrh.ox.ac.uk). The post supports a Phase III programme of work aimed at testing and validating